Juno Therapeutics (JUNO) and Dyax (DY...

Juno Therapeutics (JUNO) and Dyax (DYAX) Head to Head Survey

Juno Therapeutics and Dyax are both companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Juno Therapeutics currently has a consensus target price of $56.21, indicating a potential downside of 35.36%.

Start the conversation, or Read more at Daily Political.

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Dyax Discussions

Title Updated Last By Comments
News Dyax gets FDA approval to market Kalbitor for h... (Dec '09) Dec '09 J van Delft 1